300
Participants
Start Date
November 30, 2025
Primary Completion Date
June 2, 2026
Study Completion Date
August 2, 2026
Meloxicam 7.5 mg
This intervention is the mandatory oral Meloxicam 7.5mg dose after Mohs closure.
Meloxicam 15 mg
This intervention is the mandatory oral Meloxicam 15mg dose after Mohs closure.
Acetaminophen 500mg
This randomized control group will take a mandatory one-time dose of 500 mg acetaminophen with alternating 200 mg ibuprofen and 500 mg acetaminophen (standard of care) every 3 hours for pain.
University of Oklahoma Health Sciences Center, Oklahoma City
University of Oklahoma
OTHER